Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

How to overcome the most frustrating diabetes landmine
First trial next month, launch expected in 2-3 years; Dexcom CGM included; a big commitment to diabetes tech innovation from an insulin company
Includes insulin dose advisor software; plus, a new Novo Nordisk connected Echo insulin pen to debut in Europe later this year
The diaTribe Foundation’s first “Musings After Hours” discussion with leading experts on digital health and tech in diabetes
Dell Medical School’s Dr. Sue Cox leads SXSW 2017 panel on how redesigning medical education may improve diabetes care delivery
The 2017 Patient Voices Contest is currently open; winners will receive a full scholarship to attend the 2017 DiabetesMine Innovation Summit in Palo Alto
Initiative encourages pump and CGM devices to use “open protocols” to enable the DIY community, innovation, and more options for automated insulin delivery
Kerri Sparling on what it’s like to (attempt) balance raising young kids with managing diabetes – and how kids can be the best diabetes motivators
FDA Approves New GLP-1 Label on Victoza to show that the medicine makes hearts healthier!
How one court ruling may reverse Medicare’s policy denying coverage of most CGMs
A basal insulin and GLP-1 agonist combo becomes available in the US and receives approval in Europe
The lame food advice at Adam Brown's diagnosis, why it didn’t work, and Adam's #1 Bright Spot solution
Faster version of Novo Nordisk’s NovoLog approved in the US for type 1 and type 2 diabetes, launch expected as early as end of 2017
What it’s about, how to get a free copy, and three myths I want to bust
Instead of “avoid long-term complications,” Adam Brown focuses on something more motivating and uplifting
Learn practical tips on taking care of your feet and how to easily make them a part of daily diabetes management
Research presented at EASD 2017 showcased drugs, both new and old, that improve blood sugar management, weight loss, heart health, and even blood pressure
Tidepool, the software nonprofit that collects data from diabetes devices, announces a major new project to drive better research and products from real-world data
What’s new in smart pens and caps for capturing injection doses? Plus, two cool new health apps with built-in artificial intelligence
Seeking participants with type 2 diabetes to investigate the effects of semaglutide on heart health

Pages